Table 6 Univariate-adjusted analysis for Pericellular fibrosis
From: The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Variable Name | Sample Size | P Value | Odds Ratio | Lower OR | Upper OR |
|---|---|---|---|---|---|
Age (yrs) | 247 | 0.067 | 1.02 | 1.00 | 1.05 |
BMI (kg/m2) | 244 | 0.345 | 1.01 | 0.99 | 1.04 |
WBC (x 103/uL) | 246 | 0.467 | 1.02 | 0.97 | 1.07 |
Platelet (x 103/ul) | 242 | 0.011 | 0.99 | 0.99 | 1.00 |
IR (HOMA) | 40 | 0.008 | 2.26 | 1.24 | 4.14 |
Glucose (mg/dL) | 232 | 0.087 | 1.01 | 1.00 | 1.01 |
ALT (U/L) | 245 | 0.000 | 1.03 | 1.01 | 1.04 |
AST (U/L) | 245 | 0.000 | 1.05 | 1.02 | 1.07 |
Triglycerides (mg/dL) | 219 | 0.080 | 1.00 | 1.00 | 1.01 |
LDL (mg/dL) | 193 | 0.623 | 1.00 | 0.99 | 1.01 |
Total Cholesterol (mg/dL) | 223 | 0.338 | 1.00 | 0.99 | 1.00 |
HDL (mg/dL) | 198 | 0.003 | 0.96 | 0.94 | 0.99 |
Male | 247 | 0.000 | 4.36 | 2.43 | 7.82 |
White | 247 | 0.602 | 1.19 | 0.62 | 2.25 |
Diabetes | 247 | 0.011 | 1.99 | 1.17 | 3.38 |
Hyperlipidemia | 237 | 0.012 | 1.99 | 1.16 | 3.42 |
Hypertension | 238 | 0.254 | 1.37 | 0.80 | 2.36 |
Haplotype | |||||
 H | 247 | 0.836 | 0.95 | 0.56 | 1.61 |
 L | 247 | 0.009 | 0.23 | 0.08 | 0.70 |
 U | 247 | 0.414 | 1.37 | 0.64 | 2.93 |
 Other | 247 | 0.019 | 2.50 | 1.16 | 5.38 |
 K | 247 | 0.335 | 1.53 | 0.65 | 3.62 |
 J | 247 | 0.541 | 0.71 | 0.24 | 2.12 |
 T | 247 | 0.674 | 0.79 | 0.26 | 2.38 |
PNPLA3_SNP | |||||
 CC | Reference | ||||
 GC | 247 | 0.000 | 3.39 | 1.93 | 5.94 |
 GG | 247 | 0.370 | 0.62 | 0.22 | 1.77 |